PharmaBoardroom

Back to the Future? Global Pandemic Treaty Negotiations Rumble On

Brendan Shaw examines the protracted efforts of global stakeholders to come together around a global pandemic treaty and outlines the benefits of…

Xavier de Cuyper – CEO, Federal Agency for Medicines &…

Xavier De Cuyper of the Federal Agency for Medicines & Health Products (FAMHP), Belgium's drug regulator, explains the FAMHP's pandemic response…

Vaccines Need to Stop the Spread of COVID or Protect against New…

Airfinity's Dr Patricia Gallego highlights the persistent threat that COVID-19 continues to present to patients and healthcare systems around the…

The IFPMA’s Five Pandemic Preparedness & Response…

IFPMA Director General Thomas Cueni highlights the global innovative pharmaceutical industry’s five key priorities for ensuring better national and…

Saudi Arabia Pharma News: Riyadh Global Medical Biotech Summit…

The latest news from the Saudi healthcare and life science industry, including how the implementation of COVID-19 measures have helped reduce the…

Will We Try to Forget the Pandemic in 2023? Five Key Trends

Brendan Shaw looks ahead to the rest of 2023, identifying five key trends to watch out for in the healthcare and life sciences sector. With the worst…

Giannis Sotiriou – CEO, Institute of Pharmaceutical…

IFET is a unique institution within Greece that acts as the country's mechanism for securing access to rare disease therapies not available in the…

Chinese Pharma in 2022 & Beyond: Five Things to Know

Despite the impact of the COVID-19 pandemic and the vagaries of the country’s restrictive ‘dynamic zero COVID’ policy, the Chinese…

Hot Topics in Spanish Pharma 2022

Over the course of 2022, PharmaBoardroom spoke to over 50 leading stakeholders in the Spanish healthcare and life sciences, from top Spanish…

China Pharma News: CanSino’s Inhaled COVID-19 Vaccine Approval;…

China healthcare and life sciences news. Top stories include the NMPA approvals of CanSino’s inhaled COVID-19 vaccine and AstraZeneca’s CKD…

Japan’s New Emergency Regulatory Approval System

Pfizer’s Kaneko Miyuki, writing in the September 2022 edition of DIA’s Global Forum magazine, shines a light on Japan’s new emergency approval…

First Shipments of Homegrown Korean COVID-19 Vaccine Made

SK Bioscience’s announcement that the first batch of its domestically developed COVID vaccine has been shipped may mark a significant milestone in…

Tagged with coronavirus